Effects of theophylline and rolipram on antigen‐induced airway responses in neonatally immunized rabbits

1 The effects of the xanthine, theophylline, a non‐selective phosphodiesterase (PDE) inhibitor, and the phosphodiesterase type 4 (PDE 4) inhibitor, rolipram, were evaluated in a model of antigen‐induced airway responses in the allergic rabbit. 2 Adult litter‐matched NZW rabbits (2.5‐3.9 kg), immunized within 24 h of birth with Alternaria tenuis antigen, were pretreated twice daily for 3 days with theophylline (3 mg kg−1, i.p.) or rolipram (1 mg kg−1, i.p.) prior to antigen challenge (Alternaria tenuis). For each drug‐treated group, a parallel group of rabbits were pretreated with the appropriate vehicle. In all groups airway responsiveness to inhaled histamine and bronchoalveolar lavage (BAL) was performed 24 h before and after antigen challenge. 3 Basal lung function in terms of resistance (RL, cmH2O 1−1 s−1) and dynamic compliance (Cdyn, ml cmH2O−1) were unaltered by pretreatment with theophylline or rolipram compared to their respective vehicles 24 h prior to or post antigen challenge. 4 The acute bronchoconstriction induced by inhaled Alternaria tenuis aerosol was unaffected by pretreatment with theophylline or rolipram. 5 Airway hyperresponsiveness to inhaled histamine was indicated by reduced RL PC50 (2.4‐3.5 fold) and Cdyn PC35 (2.5‐2.6 fold) values 24 h after antigen challenge. Treatment with rolipram, but not theophylline, prevented the increase in responsiveness to inhaled histamine 24 h after antigen challenge. 6 Total cells per ml of BAL fluid increased 24 h after antigen challenge due to the recruitment of neutrophils and eosinophils. Antigen‐induced increases in pulmonary neutrophils were unaffected; however, eosinophils were reduced 57.5% in theophylline and 82% in rolipram‐treated rabbits. 7 Inhalation of Alternaria tenuis aerosol elicits an acute bronchoconstriction, followed 24 h later by an increased responsiveness to inhaled histamine and pulmonary neutrophil and eosinophil recruitment in the immunized rabbit. With the dosing regimes used, both rolipram and theophylline inhibited eosinophil recruitment, whilst only rolipram prevented the development of airway hyperresponsiveness. Neither agent inhibited the acute bronchoconstriction due to inhaled antigen.

[1]  C. Page,et al.  Regulation by phosphodiesterase isoenzymes of non‐adrenergic non‐cholinergic contraction in guinea‐pig isolated main bronchus , 1995, British journal of pharmacology.

[2]  C. Page,et al.  Capsaicin pre-treatment prevents the development of antigen-induced airway hyperresponsiveness in neonatally immunised rabbits. , 1995, European journal of pharmacology.

[3]  D. Yarnall,et al.  Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. , 1995, The Journal of pharmacology and experimental therapeutics.

[4]  L. Hendeles,et al.  Theophylline attenuation of airway responses to allergen: comparison with cromolyn metered-dose inhaler. , 1995, The Journal of allergy and clinical immunology.

[5]  C. Page,et al.  Acute versus chronic administration of phosphodiesterase inhibitors on allergen‐induced pulmonary cell influx in sensitized guinea‐pigs , 1995, British journal of pharmacology.

[6]  S. Endres,et al.  Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids , 1995, European journal of immunology.

[7]  J. Pober,et al.  cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. , 1994, The Journal of biological chemistry.

[8]  D. Underwood,et al.  Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. , 1994, The Journal of pharmacology and experimental therapeutics.

[9]  C. Andresen,et al.  Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. , 1994, American journal of respiratory and critical care medicine.

[10]  C. Page,et al.  Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.

[11]  V. Lagente,et al.  Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung. , 1994, European journal of pharmacology.

[12]  R. Pauwels,et al.  Theophylline in the management of asthma: time for reappraisal? , 1994, The European respiratory journal.

[13]  C. Advenier,et al.  Rolipram, but not siguazodan or zaprinast, inhibits the excitatory noncholinergic neurotransmission in guinea-pig bronchi. , 1994, The European respiratory journal.

[14]  C. Page,et al.  Effect of a 5‐lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on PAF‐induced airway responses in neonatally immunized rabbits , 1992, British journal of pharmacology.

[15]  E. Minshall,et al.  A novel animal model for investigating persistent airway hyperresponsiveness. , 1993, Journal of pharmacological and toxicological methods.

[16]  J. Pober,et al.  Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. , 1993, Journal of immunology.

[17]  C. Page,et al.  Theophylline--an immunomodulatory role in asthma? , 1993, The American review of respiratory disease.

[18]  B. Sickels,et al.  Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs. , 1993, The Journal of pharmacology and experimental therapeutics.

[19]  M. Yeadon,et al.  Effect of a 5‐lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen‐induced airway responses in neonatally immunized rabbits , 1994, British journal of pharmacology.

[20]  N. Frossard,et al.  Modulation by theophylline and enprofylline of the excitatory non-cholinergic transmission in guinea-pig bronchi. , 1992, The European respiratory journal.

[21]  M. Yeadon,et al.  Mechanisms contributing to ozone-induced bronchial hyperreactivity in guinea-pigs. , 1992, Pulmonary pharmacology.

[22]  M. Giembycz,et al.  Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  C. Smith,et al.  Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys. , 1991, The Journal of clinical investigation.

[24]  B. Undem,et al.  Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. , 1991, Thorax.

[25]  R. Cotran,et al.  Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions. , 1991, The Journal of clinical investigation.

[26]  R. Gerzer,et al.  Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells. , 1991, Immunology.

[27]  R. Gristwood,et al.  Effects of theophylline compared with prednisolone on late phase airway leukocyte infiltration in guinea pigs. , 1991, International archives of allergy and applied immunology.

[28]  T. Andersson,et al.  Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: smooth muscle tone, platelet aggregation and cAMP levels. , 1990, Acta physiologica Scandinavica.

[29]  J. Lanchbury,et al.  A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. , 1990, Journal of immunology.

[30]  J. Beavo,et al.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. , 1990, Trends in pharmacological sciences.

[31]  P. Bruijnzeel Contribution of eosinophil-derived mediators in asthma. , 1989, International archives of allergy and applied immunology.

[32]  P. Barnes Our changing understanding of asthma. , 1989, Respiratory medicine.

[33]  P. O'Byrne,et al.  Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholine. , 1989, The Journal of allergy and clinical immunology.

[34]  J. Palmer,et al.  Airway cholinergic responsiveness in rabbits in relation to antigen sensitization and challenge. , 1988, Immunopharmacology.

[35]  L. Fabbri,et al.  Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects. , 1987, The American review of respiratory disease.

[36]  R. Pauwels The effects of theophylline on airway inflammation. , 1987, Chest.

[37]  G. Larsen,et al.  The inflammatory reaction in the airways in an animal model of the late asthmatic response. , 1987, Federation proceedings.

[38]  R. Pauwels,et al.  The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. , 1985, The Journal of allergy and clinical immunology.

[39]  W. Marsh,et al.  Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. , 1985, The American review of respiratory disease.

[40]  L. Hendeles,et al.  Pharmacologic management of reversible obstructive airways disease. , 1981, The Medical clinics of North America.

[41]  B. Fredholm,et al.  Are methylxanthine effects due to antagonism of endogenous adenosine , 1979 .

[42]  A. Lendrum The staining of eosinophil polymorphs and enterochromaffin cells in histological sections , 1944 .